Mathematical Models in Schizophrenia

Schizophrenia is a severe and complex mental disorder that causes an enormous societal and financial burden. Our current understanding of schizophrenia is very fragmented, and the disease is still regarded as an enigma even though its main features have been recognized for centuries. When the post-genomic era arrived, high-throughput instruments and methods ushered in an explosion in the generation of large datasets. This rich information began to facilitate the development of mathematical models, and these models are beginning to show the potential of propelling schizophrenia research onto a new, quantitative level. As schizophrenia is a complex disease that involves uncounted biological processes, there is no complete model which covers even the majority of aspects pertaining to schizophrenia. Instead, every currently available model focuses on a certain aspect of the disease. In this chapter, we review mathematical models of schizophrenia according to their mathematical foundation and structure, as well as the phenomenon they represent. Thus, an outline of mathematical modeling practices in schizophrenia is presented for biologists, psychiatrists, and clinicians. In the future, mathematical models may be expected to provide valuable guidance in the long-term investigation of complex diseases like schizophrenia.

[1]  A linear mathematical model for computerized analyses of mood curves , 1987, European archives of psychiatry and neurological sciences.

[2]  E. Kringlen Twin studies in schizophrenia with special emphasis on concordance figures. , 2000, American journal of medical genetics.

[3]  E. Walker,et al.  The stress cascade and schizophrenia: etiology and onset. , 2003, Schizophrenia bulletin.

[4]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Tretter,et al.  Systems Biology and Psychiatry – Modeling Molecular and Cellular Networks of Mental Disorders , 2008, Pharmacopsychiatry.

[6]  Marc W Howard,et al.  Modeling of context-dependent retrieval in hippocampal region CA1: Implications for cognitive function in schizophrenia , 2007, Schizophrenia Research.

[7]  René Thom,et al.  Structural stability and morphogenesis , 1977, Pattern Recognit..

[8]  Jeanette Kotaleski,et al.  Transient Calcium and Dopamine Increase PKA Activity and DARPP-32 Phosphorylation , 2006, PLoS Comput. Biol..

[9]  J. Endicott,et al.  Brief hospitalization: a two-year follow-up. , 1977, The American journal of psychiatry.

[10]  G. Carey,et al.  Codistribution of a sensory gating deficit and schizophrenia in multi-affected families , 1991, Psychiatry Research.

[11]  X-J Wang,et al.  Toward a Prefrontal Microcircuit Model for Cognitive Deficits in Schizophrenia , 2006, Pharmacopsychiatry.

[12]  R. Neufeld,et al.  Cognitive processing of facial affect: connectionist model of deviations in schizophrenia. , 2007, Journal of abnormal psychology.

[13]  W. Wilson A Visual Guide to Expected Blood Levels of Long-Acting Injectable Risperidone in Clinical Practice , 2004, Journal of psychiatric practice.

[14]  G. Strauss,et al.  Factor analytic support for social cognition as a separable cognitive domain in schizophrenia , 2007, Schizophrenia Research.

[15]  J. Waddington,et al.  Catastrophe theory: a model interaction between neurochemical and environmental influences in the control of schizophrenia. , 1979, Neuropsychobiology.

[16]  E. Kraepelin Psychiatrie : ein Lehrbuch für Studi[e]rende und Aerzte , 1976 .

[17]  A. Geva,et al.  The Perception of Rorschach Inkblots in Schizophrenia: a Neural Network Model , 2000, The International journal of neuroscience.

[18]  A. Carlsson,et al.  3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists , 1957, Nature.

[19]  E O Voit,et al.  A Mathematical Model of Presynaptic Dopamine Homeostasis: Implications for Schizophrenia , 2008, Pharmacopsychiatry.

[20]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[21]  M. Lindskog,et al.  Modelling of DARPP-32 Regulation to Understand Intracellular Signaling in Psychiatric Disease , 2008, Pharmacopsychiatry.

[22]  Gregory G. Brown,et al.  Performance of schizophrenia and bipolar patients on verbal and figural working memory tasks. , 2007, Journal of abnormal psychology.

[23]  D Sigulem,et al.  Decision support system for the diagnosis of schizophrenia disorders. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[24]  N. Novère Neurological disease: are systems approaches the way forward? , 2008 .

[25]  Yhpho,et al.  Mental health: Reports , 2009 .

[26]  Nicolas Le Novère,et al.  DARPP-32 Is a Robust Integrator of Dopamine and Glutamate Signals , 2006, PLoS Comput. Biol..

[27]  G. Simpson,et al.  A paradox in the prognosis of schizophrenia. explanation by a mathematical model. , 1977, Journal of theoretical biology.

[28]  Anissa Abi-Dargham,et al.  Alterations of serotonin transmission in schizophrenia. , 2007, International review of neurobiology.

[29]  A. Hodgkin,et al.  A quantitative description of membrane current and its application to conduction and excitation in nerve , 1952, The Journal of physiology.

[30]  A. Caspi,et al.  Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction , 2005, Biological Psychiatry.

[31]  D. Rosenhan On Being Sane in Insane Places , 1973, Science.

[32]  J. Girault,et al.  DARPP-32 is a robust integrator of dopamine and glutamate signals , 2006 .

[33]  Michael J Owen,et al.  Recent advances in the genetics of schizophrenia. , 2003, Human molecular genetics.

[34]  T. Crow,et al.  Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. , 2005, The American journal of psychiatry.

[35]  M. Tsuang,et al.  Genetic epidemiology of schizophrenia: review and reassessment. , 1998, The Kaohsiung journal of medical sciences.

[36]  D. Umbricht,et al.  Mismatch negativity in schizophrenia: a meta-analysis , 2005, Schizophrenia Research.

[37]  L. Finkel,et al.  NMDA/AMPA Ratio Impacts State Transitions and Entrainment to Oscillations in a Computational Model of the Nucleus Accumbens Medium Spiny Projection Neuron , 2005, The Journal of Neuroscience.

[38]  Karen A. Moxon,et al.  Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus , 2003, Biological Cybernetics.

[39]  B. Saraceno,et al.  The WHO World Health Report 2001 on mental health , 2002, Epidemiologia e Psichiatria Sociale.

[40]  Jonathan D. Cohen,et al.  Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function , 1999, Biological Psychiatry.

[41]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[42]  H. Möller,et al.  A non-linear mathematical model for computerized analysis of mood curves: construction of the model and its application to the mood curves of depressive and schizophrenic inpatients. , 1988, Journal of affective disorders.

[43]  G. Tucker,et al.  Factors related to short-term prognosis in schizophrenia and depression. , 1971, Archives of general psychiatry.

[44]  Eberhard O. Voit,et al.  The internal state of medium spiny neurons varies in response to different input signals , 2010, BMC Systems Biology.

[45]  D. Rao,et al.  Mixed-model segregation analysis of schizophrenia in the lindelius Swedish pedigrees , 1990, Behavior genetics.

[46]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[47]  Angus W MacDonald,et al.  What we know: findings that every theory of schizophrenia should explain. , 2009, Schizophrenia bulletin.

[48]  Todd S. Woodward,et al.  Brain activation mediates the association between structural abnormality and symptom severity in schizophrenia , 2007, NeuroImage.

[49]  A. Amos A Computational Model of Information Processing in the Frontal Cortex and Basal Ganglia , 2000, Journal of Cognitive Neuroscience.

[50]  Shoji Tanaka Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation , 2007, BMC Neuroscience.

[51]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Jelliffe Handbuch, der Psychiatrie , 1914 .

[53]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[54]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[55]  K. Berman Cortical “stress tests” in schizophrenia: Regional cerebral blood flow studies , 1987, Biological Psychiatry.

[56]  E. Bleuler [Dementia praecox or the group of schizophrenias]. , 1968, Vertex.

[57]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[58]  Y Satomura,et al.  A Psychiatric Diagnostic System Integrating Probabilistic and Categorical Reasoning , 1995, Methods of Information in Medicine.

[59]  J. Fleiss,et al.  Rehospitalization in Chronic Schizophrenia , 1985, The Journal of nervous and mental disease.

[60]  J A Reggia,et al.  Pathogenesis of schizophrenic delusions and hallucinations: a neural model. , 1996, Schizophrenia bulletin.

[61]  Nicholas Lange,et al.  What can modern statistics offer imaging neuroscience? , 2003, Statistical methods in medical research.

[62]  Dai Zhang,et al.  Two-stage designs to identify the effects of SNP combinations on complex diseases , 2008, Journal of Human Genetics.

[63]  E. Bromet,et al.  Premorbid functioning and outcome in schizophrenics and nonschizophrenics. , 1974, Archives of general psychiatry.

[64]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[65]  P. Sham,et al.  Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. , 2005, JAMA.

[66]  W. Griesinger Die Pathologie und Therapie der psychischen Krankheiten für Aerzte und Studirende , 2006 .

[67]  S. Moore,et al.  Jumping to conclusions: A network model predicts schizophrenic patients’ performance on a probabilistic reasoning task , 2006, Cognitive, affective & behavioral neuroscience.

[68]  Recognition of hallucinations: a new multidimensional model and methodology. , 1996, Psychopathology.

[69]  L. Danziger,et al.  Mechanism of periodic catatonia. , 1958, Confinia neurologica.

[70]  A. Carlsson,et al.  The occurrence, distribution and physiological role of catecholamines in the nervous system. , 1959, Pharmacological reviews.

[71]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[72]  U. an der Heiden Schizophrenia as a dynamical disease. , 2006 .

[73]  E O Voit,et al.  Computational Modeling of Synaptic Neurotransmission as a Tool for Assessing Dopamine Hypotheses of Schizophrenia , 2010, Pharmacopsychiatry.

[74]  A. Sampson,et al.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.

[75]  J. Jesberger,et al.  A model of smooth pursuit performance illustrates the relationship between gain, catch-up saccade rate, and catch-up saccade amplitude in normal controls and patients with schizophrenia , 1991, Biological Psychiatry.

[76]  Jessica A. Turner,et al.  Imaging phenotypes and genotypes in schizophrenia , 2007, Neuroinformatics.

[77]  John G. Taylor,et al.  A neural model of working memory processes in normal subjects, Parkinson's disease and schizophrenia for fMRI design and predictions , 2000, Neural Networks.

[78]  N. Schmajuk,et al.  Latent inhibition: a neural network approach. , 1996, Journal of experimental psychology. Animal behavior processes.

[79]  P. Liddle The Symptoms of Chronic Schizophrenia , 1987, British Journal of Psychiatry.

[80]  Jane Cronin‐Scanlon A MATHEMATICAL MODEL FOR CATATONIC SCHIZOPHRENIA * , 1974, Annals of the New York Academy of Sciences.

[81]  H. Schwegler Phenomenological modelling of some mechanisms in schizophrenia. , 2006, Pharmacopsychiatry.

[82]  S. Faraone,et al.  Mathematical models of complex dose-response relationships: implications for experimental design in psychopharmacologic research. , 1992, Statistics in medicine.

[83]  L. Danziger,et al.  Mathematical theory of periodic relapsing catatonia , 1954 .

[84]  M. Leboyer,et al.  Admixture analysis of age at onset in schizophrenia , 2004, Schizophrenia Research.

[85]  O. Gambini,et al.  An artificial neural network that uses eye-tracking performance to identify patients with schizophrenia. , 1999, Schizophrenia bulletin.

[86]  D Servan-Schreiber,et al.  A theory of dopamine function and its role in cognitive deficits in schizophrenia. , 1993, Schizophrenia bulletin.

[87]  E. Caffey,et al.  Brief hospitalizaion and aftercare in the treatment of schizophrenia. , 1971, Archives of general psychiatry.

[88]  J. Port,et al.  A theory of cooperativity modulation in neural networks as an important parameter of CNS catecholamine function and induction of psychopathology. , 1994, Neurological research.

[89]  J. Strauss,et al.  The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. , 1974, Schizophrenia bulletin.

[90]  N. Risch,et al.  Segregation analysis of schizophrenia and related disorders. , 1984, American journal of human genetics.